ENO2 and neoplasm: The immunobiological study of the tumour markers typically demonstrates positivity of neuron-specific enolase (74.1–90%), CgA (66.7–95%), and synaptophysin (48.9–91.7%) and CD56 and cytokeratin [14, 15, 23].